Diagnosis of Myasthenia Gravis

Overview

Journal J Clin Med

Specialty General Medicine

Date 2021 Apr 30

PMID 33923771

Citations 21

Authors

Rossen T Rousseff

Affiliations

Soon will be listed here.

Abstract

The diagnosis of autoimmune Myasthenia Gravis (MG) remains clinical and rests on the history and physical findings of fatigable, fluctuating muscle weakness in a specific distribution. Ancillary bedside tests and laboratory methods help confirm the synaptic disorder, define its type and severity, classify MG according to the causative antibodies, and assess the effect of treatment objectively. We present an update on the tests used in the diagnosis and follow-up of MG and the suggested approach for their application.

Citing Articles

Factors affecting the diagnostic delay of myasthenia gravis.

Marlet I, Andersen R, Axelsen K, Andersen L, Vissing J, Witting N J Neurol. 2024; 272(1):29.

PMID: 39665854 DOI: 10.1007/s00415-024-12807-1.

Characterizing Myasthenia Gravis Symptoms, Exacerbations, and Crises From Neurologist's Clinical Notes Using Natural Language Processing.

Darer J, Pesa J, Choudhry Z, Batista A, Parab P, Yang X Cureus. 2024; 16(7):e65792.

PMID: 39219871 PMC: 11361825. DOI: 10.7759/cureus.65792.

Decoding myasthenia gravis: advanced diagnosis with infrared spectroscopy and machine learning.

Severcan F, Ozyurt I, Dogan A, Severcan M, Gurbanov R, Kucukcankurt F Sci Rep. 2024; 14(1):19316.

PMID: 39164310 PMC: 11336246. DOI: 10.1038/s41598-024-66501-3.

Should We Consider Routine Blood Work for Diplopia and Ptosis in a Primary Care Setting?.

Dietlein W, Dickey Z, Aldret S Cureus. 2024; 16(5):e60521.

PMID: 38882969 PMC: 11180514. DOI: 10.7759/cureus.60521.

Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis.

Chae J, Nguyen T, Oh S J Neurol. 2024; 271(8):5035-5045.

PMID: 38796801 DOI: 10.1007/s00415-024-12461-7.

References

Rajput R, Sachdev A, Din N, Damato E, Murray A . False positive acetylcholine receptor antibodies in a case of unilateral chronic progressive external ophthalmoplegia: case report and review of literature. Orbit. 2018; 37(5):385-388. DOI: 10.1080/01676830.2017.1423350. View

Oh S . Distinguishing Features of the Repetitive Nerve Stimulation Test Between Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis, 50-Year Reappraisal. J Clin Neuromuscul Dis. 2017; 19(2):66-75. DOI: 10.1097/CND.0000000000000190. View

Sussman J, Farrugia M, Maddison P, Hill M, Leite M, Hilton-Jones D . Myasthenia gravis: Association of British Neurologists' management guidelines. Pract Neurol. 2015; 15(3):199-206. DOI: 10.1136/practneurol-2015-001126. View

Gilhus N, Tzartos S, Evoli A, Palace J, Burns T, Verschuuren J . Myasthenia gravis. Nat Rev Dis Primers. 2019; 5(1):30. DOI: 10.1038/s41572-019-0079-y. View

Katz B, Miledi R . The binding of acetylcholine to receptors and its removal from the synaptic cleft. J Physiol. 1973; 231(3):549-74. PMC: 1350679. DOI: 10.1113/jphysiol.1973.sp010248. View

OSSERMAN K, KAPLAN L . Rapid diagnostic test for myasthenia gravis: increased muscle strength, without fasciculations, after intravenous administration of edrophonium (tensilon) chloride. J Am Med Assoc. 1952; 150(4):265-8. DOI: 10.1001/jama.1952.03680040007002. View

Sanders D . Clinical impact of single-fiber electromyography. Muscle Nerve Suppl. 2002; 11:S15-20. DOI: 10.1002/mus.10141. View

Sanders D, Arimura K, Cui L, Ertas M, Farrugia M, Gilchrist J . Guidelines for single fiber EMG. Clin Neurophysiol. 2019; 130(8):1417-1439. DOI: 10.1016/j.clinph.2019.04.005. View

Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R . A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun. 2013; 52:139-45. DOI: 10.1016/j.jaut.2013.12.004. View

10.

Frykman H, Kumar P, Oger J . Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies. Front Neurol. 2020; 11:596621. PMC: 7755715. DOI: 10.3389/fneur.2020.596621. View

11.

Lamb C, Rubin D . Sensitivity and specificity of repetitive nerve stimulation with lower cutoffs for abnormal decrement in myasthenia gravis. Muscle Nerve. 2020; 62(3):381-385. DOI: 10.1002/mus.26999. View

12.

Meriggioli M, Sanders D . Myasthenia gravis: diagnosis. Semin Neurol. 2004; 24(1):31-9. DOI: 10.1055/s-2004-829594. View

13.

Zhang J, Chen Y, Chen J, Huang X, Wang H, Li Y . AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?. Neurol Sci. 2021; 42(3):863-869. PMC: 7870615. DOI: 10.1007/s10072-021-05042-3. View

14.

Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A . Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001; 7(3):365-8. DOI: 10.1038/85520. View

15.

Al-Hashel J, Rousseff R, Khuraibet A, Tzvetanov P . Single-fiber electromyography of facial and limb muscles in diabetic patients with or without neuropathy. J Clin Neurophysiol. 2014; 31(5):450-5. DOI: 10.1097/WNP.0000000000000087. View

16.

Abraham A, Breiner A, Barnett C, Katzberg H, Lovblom L, Rt M . Electrophysiological testing is correlated with myasthenia gravis severity. Muscle Nerve. 2016; 56(3):445-448. DOI: 10.1002/mus.25539. View

17.

Bou Ali H, Salort-Campana E, Grapperon A, Gallard J, Franques J, Sevy A . New strategy for improving the diagnostic sensitivity of repetitive nerve stimulation in myasthenia gravis. Muscle Nerve. 2016; 55(4):532-538. DOI: 10.1002/mus.25374. View

18.

Evoli A, Antonini G, Antozzi C, DiMuzio A, Habetswallner F, Iani C . Italian recommendations for the diagnosis and treatment of myasthenia gravis. Neurol Sci. 2019; 40(6):1111-1124. DOI: 10.1007/s10072-019-03746-1. View

19.

Higuchi O, Hamuro J, Motomura M, Yamanashi Y . Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol. 2011; 69(2):418-22. DOI: 10.1002/ana.22312. View

20.

Juel V . Clinical neurophysiology of neuromuscular junction disease. Handb Clin Neurol. 2019; 161:291-303. DOI: 10.1016/B978-0-444-64142-7.00055-2. View